SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-043985
Filing Date
2021-06-30
Accepted
2021-06-30 16:51:39
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2736
2 POA DOCUMENT poa.txt EX-24.3_996345 3175
  Complete submission text file 0001209191-21-043985.txt   7352
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Issuer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LUCIRA HEALTH, INC. 1412 62ND STREET EMERYVILLE CA 94608
Business Address
Collins Kevin Walter (Reporting) CIK: 0001870312 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39976 | Film No.: 211062547